Related Experiment Video
Updated: Jun 23, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Factors associated with glycemic control after an inpatient program
Satoko Maruyama1, Hiroshi Sakura, Hiroko Kanno
1Diabetes Center, Tokyo Women's Medical University, Tokyo 162-8666, Japan.
Metabolism: Clinical and Experimental
|May 19, 2009
Summary
Longer diabetes duration and more hospital admissions predict poor glycemic control in type 2 diabetes patients post-inpatient care. These factors indicate challenges in managing blood sugar levels effectively.
Area of Science:
- Endocrinology
- Diabetes Management
- Public Health
Background:
- Type 2 diabetes mellitus (T2DM) management requires effective inpatient programs.
- Predicting post-discharge glycemic control is crucial for long-term patient outcomes.
- Identifying factors associated with poor glycemic control can inform targeted interventions.
Purpose of the Study:
- To investigate predictors of poor glycemic control (hemoglobin A1C [HbA1C] ≥ 7.0%) six months after an inpatient program for T2DM.
- To identify factors associated with a poor glycemic response (absolute HbA1C decrease < 1.5%) six months after an inpatient program.
Main Methods:
- Retrospective analysis of a hospital database (April 1999 - May 2003).
- Inclusion criteria: T2DM patients with HbA1C ≥ 8.0% at admission.
- Stepwise multivariate regression analysis to identify predictors of poor glycemic control and response.
Main Results:
- Primary analysis: Duration of diabetes (OR, 2.43), time from first hospital attendance to admission (OR, 1.60), and number of admissions (OR, 2.28) predicted poor glycemic control.
- Secondary analysis: Duration of diabetes (OR, 2.17), time from first hospital attendance to admission (OR, 2.17), diabetes treatment at discharge (oral agents OR, 2.52; insulin OR, 4.44), baseline HbA1C (OR, 0.44), and addition of new medications (OR, 0.41) predicted poor glycemic response.
Conclusions:
- Longer diabetes duration, increased hospital admissions, and longer time since initial hospital contact are significant predictors of sustained poor glycemic control.
- Diabetes treatment strategies at discharge, including medication adjustments, play a role in glycemic response.
- These findings highlight the need for tailored post-inpatient care strategies for T2DM patients with specific risk factors.
Related Concept Videos
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:14SBAR II: Application of SBAR
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...